Aquestive Therapeutics (AQST) vs Citius Oncology (CTOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aquestive Therapeutics (AQST) has outperformed Citius Oncology (CTOR) over the past year, losing 23.2% versus a loss of 54.6%. Aquestive Therapeutics is the larger company by market cap ($597.4 million vs $88.3 million), about 6.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | CTOR |
|---|---|---|
| Share price | $4.76 | $0.835 |
| Market cap | $597.44M | $88.31M |
| 1-day change | +3.03% | -2.45% |
| YTD return | -26.32% | -16.50% |
| 1-year return | -23.23% | -54.62% |
| 5-year return | +23.00% | — |
| EPS (TTM) | $-0.66 | $-0.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $2.25 |
| 52-week low | $2.93 | $0.491 |
| Distance from 52-week high | -36.95% | -62.89% |
| Analyst consensus | none | none |
| Avg. price target upside | +96.01% | +379.04% |
| Average volume | 2.68M | 99.72K |
| Shares outstanding | 125.51M | 105.76M |
| Employees | 147 | — |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aquestive Therapeutics is about 6.8 times larger than Citius Oncology by market value ($597.44M vs $88.31M).
- AQST has outperformed CTOR by 31.4 percentage points over the past year.
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 147 employees
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Healthcare · Drug Manufacturers - Specialty & Generic
AQST vs CTOR FAQ
Which is bigger, Aquestive Therapeutics or Citius Oncology?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $597.44M compared with $88.31M for Citius Oncology (CTOR).
Which stock has performed better over the past year, AQST or CTOR?
AQST returned -23.23% over the past 12 months, compared with -54.62% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and Citius Oncology in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.